Etanercept is a biological disease modifying agent used in the management of rheumatoid ahritis. its mechanism of action is
**Core Concept**
Etanercept is a tumor necrosis factor-alpha (TNF-α) inhibitor, which means it works by blocking the action of TNF-α. This cytokine plays a key role in the inflammatory process and is involved in the pathogenesis of rheumatoid arthritis.
**Why the Correct Answer is Right**
Etanercept binds to TNF-α, preventing it from interacting with its receptors on the surface of immune cells. This inhibits the activation of downstream signaling pathways that lead to inflammation and joint damage. By blocking TNF-α, etanercept reduces the severity of symptoms and slows disease progression in patients with rheumatoid arthritis.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because etanercept does not work by inhibiting IL-1 (interleukin 1), which is another cytokine involved in the inflammatory process. While IL-1 inhibitors do exist, etanercept targets TNF-α specifically.
**Option B:** This option is incorrect because etanercept is not a corticosteroid. While corticosteroids are used to treat rheumatoid arthritis, they have a different mechanism of action and are not targeted therapies like etanercept.
**Option C:** This option is incorrect because etanercept is not a DMARD (disease-modifying antirheumatic drug) that works by inhibiting pyrimidine synthesis. While some DMARDs do work in this way, etanercept's mechanism is distinct.
**Clinical Pearl / High-Yield Fact**
Etanercept is a type of biologic agent that targets the TNF-α pathway, which is also involved in other inflammatory conditions such as psoriasis and Crohn's disease. This makes it a useful treatment option for patients with multiple inflammatory conditions.
**Correct Answer:** C.